Phase I Study of the Safety, Tolerance, and Pharmacokinetics of 9-[2-(Bispivaloyloxymethyl)Phosphonylmethoxyethyl]Adenine (Bis-POM PMEA; Adefovir Dipivoxil) in HIV-Infected Patients - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

Phase I Study of the Safety, Tolerance, and Pharmacokinetics of 9-[2-(Bispivaloyloxymethyl)Phosphonylmethoxyethyl]Adenine (Bis-POM PMEA; Adefovir Dipivoxil) in HIV-Infected Patients

This study has been completed.

Study NCT00002128. Last updated on June 23, 2005. Information provided by NIH AIDS Clinical Trials Information Service

Please refer to this study by its ClinicalTrials.gov identifier: NCT00002128

Locations


United States, Maryland
	Johns Hopkins Univ
	Baltimore, Maryland, United States, 21205

Sponsors and Collaborators

Gilead Sciences